Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: A Quasi-Experimental Study

Introduction: Estimated rates of past-month cannabidiol (CBD) use in the general public are 13–26% and emerging research examines CBD as a potential adjunct treatment for several medical conditions, including stress-related disorders (e.g., depression, anxiety, and chronic pain). However, little is...

Full description

Bibliographic Details
Main Authors: Mohammed Faraj, Tyler Dautrich, Leslie Lundahl, Hilary Marusak
Format: Article
Language:English
Published: Karger Publishers 2023-11-01
Series:Medical Cannabis and Cannabinoids
Subjects:
Online Access:https://beta.karger.com/Article/FullText/531886